147807-85-0

Upstream product

• 645-36-3 2,2-diethoxy-ethanamine 
• 147807-84-9 Benzyloxymethyl 2-benzyloxy-3-methoxy-4-methylphenyl ketone 
• 100-44-7 benzyl chloride 
• 147807-83-8 2-Benzyloxy-1-(2-benzyloxy-3-methoxy-4-methyl-phenyl)-ethanol 
• 147807-81-6 (2-Benzyloxy-3-methoxy-4-methylphenyl)oxirane 
• 123042-12-6 2-benzyloxy-3-methoxy-4-methylbenzaldehyde 
• 147807-80-5 2?hydroxy?3?methoxy?4?methylbenzaldehyde 
• 4463-33-6 1,2-dimethoxy-3-methylbenzene 
• 75889-47-3 2,3-dimethoxy-4-methylbenzaldehyde 

Downstream Products

• 147807-89-4 8-Benzyloxy-1-benzyloxymethyl-7-methoxy-6-methyl-2-(p-tolylsulfonyl)-1,2-dihydroisoquinoline 
• 1027896-93-0 1-Hydroxymethyl-7-methoxy-6-methyl-2-(toluene-4-sulfonyl)-1,2,3,4-tetrahydro-isoquinolin-8-ol 
• 147807-86-1 6-[1-(2,2-Diethoxy-ethylamino)-2-hydroxy-ethyl]-2-methoxy-3-methyl-phenol 
• 147807-88-3 N-(2,2-Diethoxyethyl)-N-<1-(2-benzyloxy-3-methoxy-4-methylphenyl)-2-benzyloxyethyl>toluene-p-sulfonamide 

Relevant academic research and scientific papers

Total synthesis of the β-adrenergic receptor antagonist, the tetrahydroisoquinoline MY336-a and its epimer

The first total synthesis of the novel β-adrenergic receptor antagonist MY336-a 1 and its epimer 2 has been achieved from 2,3-dimethoxytoluene, by Jackson cyclisation of N-benzyl-N-tosylamido acetals, Lewis acid-mediated addition of silicon-based nucleoph

Studies on the Natural β-Adrenergic Receptor Antagonist MY336-a: Synthesis of a 3-Dehydroxymethyl Analogue

The preparation of a polysubstituted tetrahydroisoquinoline, which lacks only the 3-CH2OH group of MY336-a, is described.